ES
MARKETS / NYSE / NHC
NYSE · SERVICES-SKILLED NURSING CARE FACILITIES · LARGE CAP

National Healthcare Corp. NHC

17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY12 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$1.5B
▲ 17.4% vs FY2024
Dividend streak
12 yrs
Raised every year since 2014
EPS · FY25
$7.67
Dividend / sh · FY25
$2.53
Payout · FY25
32%
ROE · FY25
11.7%
Net margin · FY25
8.2%
Dividend coverage
3.0×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.5B
Revenue, FY2025 · full 17-year series below
Revenue Net income
0.40.81.21.61.50.12009201220152018202120242025
0.40.81.21.61.50.12016201920222025

8 cents of every revenue dollar became profit this year.

Per share
USD 7.67
Diluted EPS, FY2025
EPS Dividend
48122.537.672009201220152018202120242025
48122.537.672016201920222025

Earnings covered the dividend 3.0 times — the rest stayed in the company.

Profitability
11.7%
Return on equity, FY2025
ROE
510152011.7%2009201220152018202120242025
510152011.7%2016201920222025
Operating margin8.7%
Net margin8.2%
Return on assets7.9%

Each USD of equity produced 12 cents of profit this year.

Returned to shareholders
USD 39.2M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 38.7M
Net buybacksUSD 516,000.00
Share of profit32.7%
Consecutive raises12 years

USD 38.7M in dividends and USD 516,000.00 in buybacks — 33% of the year's profit went back to shareholders.

Growth
+9.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+12.6%
+9.5%
Net income
+74.9%
+23.4%
+8.5%
+5.6%
EPS, diluted
+74.2%
+23.0%
+9.1%
+6.0%
Dividend / share
+3.8%
+4.0%
+5.1%
Returned to shareholders
−2.6%
+4.2%
+6.4%
+5.3%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.02B
Shares outstanding, FY2025
0.010.022009201220152018202120242025
0.020.022016201920222025
Change, 5 years+1.1%
Change, 10 years+3.6%

The share count grew 1% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.5B
total assets, end of FY2025
Total assetsUSD 1.5B
EquityUSD 1.1B
CashUSD 92.8M
Gross debtUSD 40.0M
Net debtUSD -52.8M
Current ratio1.82×

The company holds more cash than debt.

History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
1.5
1.3
1.1
1.0
1.0
0.9
0.9
0.9
0.9
0.9
·
·
·
·
·
·
·
Operating income $B
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
EBITDA $B
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
EPS, diluted $
7.67
6.53
4.34
1.45
8.99
2.72
4.44
3.87
3.69
3.32
3.20
3.14
3.87
3.57
3.96
3.22
2.31
Dividend / sh $
2.53
2.42
2.34
2.26
2.11
2.08
2.06
1.98
1.89
1.75
1.54
1.34
1.26
2.20
1.18
·
·
Payout %
32
36
53
154
23
76
46
51
50
51
40
35
27
52
25
28
34
ROE %
11.7
10.8
7.5
2.5
16.3
5.3
9.0
8.2
8.2
7.8
7.8
7.5
9.6
9.4
11.2
9.7
7.6
Shares out B
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
49 of 49
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed